Neurotoxins, parkinsonism and Parkinson's disease
- 1 January 1987
- journal article
- review article
- Published by Elsevier in Pharmacology & Therapeutics
- Vol. 32 (1) , 19-49
- https://doi.org/10.1016/0163-7258(87)90062-3
Abstract
No abstract availableThis publication has 108 references indexed in Scilit:
- Metabolism of the neurotoxic tertiary amine, MPTP, by brain monoamine oxidasePublished by Elsevier ,2004
- Systemic administration of antioxidants does not protect mice against the dopaminergic neurotoxicity of 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine (MPTP)Neuroscience Letters, 1986
- Partial protection from the dopaminergic neurotoxin N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine by four different antioxidants in the mouseNeuroscience Letters, 1985
- Active uptake of MPP+, a metabolite of MPTP, by brain synaptosomesBiochemical and Biophysical Research Communications, 1985
- VI. Dopaminergic neurotoxicity of 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine (MPTP) in the mouse: Relationships between monoamine oxidase, MPTP metabolism and neurotoxicityLife Sciences, 1985
- II. Selective accumulation of MPP+ in the substantia nigra: A key to neurotoxicity?Life Sciences, 1985
- Oxidation of the neurotoxic amine 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) by monoamine oxidases A and B and suicide inactivation of the enzymes by MPTPBiochemical and Biophysical Research Communications, 1984
- Active Oxygen Species and the Functions of Phagocytic LeukocytesAnnual Review of Biochemistry, 1980
- The effect of age on the activity and molecular properties of human brain monoamine oxidaseJournal Of Neural Transmission-Parkinsons Disease and Dementia Section, 1980
- Behavior of Free-Ranging Macaques after Intraventricular 6-HydroxydopamineScience, 1973